Miscellanea

Symposium 6 shed light on the autonomic disorders in a broad range of neurological and paraphysiological conditions through either pre-clinical and clinical studies as well as novel treatment approaches.

The autonomic nervous system (ANS) is in some ways distinct from other parts of the nervous system: ANS function cannot be easily measured, only some ANS parts are accessible to imaging. Moreover, working in the field of ANS requires a multidisciplinary approach to clinical problems and often involves other specialities such as cardiology, gastroenterology, dermatology, and urology.

The Scientific Panel on Movement Disorders Management Group invites you to join us for the excellent Movement Disorders program at the EAN Virtual Congress.  The program has been prepared in collaboration between the EAN and the International Parkinson and Movement Disorder… Continue Reading

The arrival of the COVID-19 pandemic in my French region and also in Grenoble has radically changed how teaching classes have been organised in our Grenoble Alpes University Medical School. To better explain these changes, I need to illustrate how… Continue Reading

As any place in Europe and beyond, the French health system is still under pressure and Covid-19 has already and will profoundly change healthcare.

Giovanni Di Liberto, MD-PhD Chair, RRFS – Residents and Research Fellows Section of the EAN Dr. Thomas Jenkins, Chair of the EAN e-Communication Committee interviews: Dear Dr. Di Liberto, You recently took over the leadership of the RRFS EAN section.… Continue Reading

New gene therapy to treat spinal muscular atrophy On March 27, European Medicines Agency (EMA) recommended granting a conditional marketing authorisation in the European Union for the gene therapy Zolgensma (onasemnogene abeparvovec) to treat babies and young children with spinal… Continue Reading

Discussions during last year’s Spring Meeting and General Assembly showed that BioMed Alliance Members are affected by Plan S. Due to COVID-19, adaptation to the open access initiative within the foreseen timeline has become even more challenging for medical societies.… Continue Reading

EMA has published its Regulatory Science Strategy to 2025 today. The strategy provides a plan for advancing regulatory science over the next five years, covering both human and veterinary medicines. It comes in response to the dramatic acceleration of the… Continue Reading

The latest revision (v3) of the Guidance on how to manage clinical trials during the COVID-19 pandemic was published on 28 April. This version contains key changes based also on the feedback from different stakeholders’ groups (patients’ organisations, academia and… Continue Reading

Prof. Dafin Muresanu, Chair of the EAN Communication Committee interviews Dr. Bart van der Worp, President of the European Stroke Organisation.